16-173598-T-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM4PP5_Very_Strong
The NM_000517.6(HBA2):āc.427T>Gā(p.Ter143Gluext*?) variant causes a stop lost change. The variant allele was found at a frequency of 0.00000435 in 1,608,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 25)
Exomes š: 0.0000034 ( 0 hom. )
Consequence
HBA2
NM_000517.6 stop_lost
NM_000517.6 stop_lost
Scores
3
4
Clinical Significance
Conservation
PhyloP100: 4.12
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM4
Stoplost variant in NM_000517.6 Downstream stopcodon found after 154 codons.
PP5
Variant 16-173598-T-G is Pathogenic according to our data. Variant chr16-173598-T-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 15653.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBA2 | NM_000517.6 | c.427T>G | p.Ter143Gluext*? | stop_lost | 3/3 | ENST00000251595.11 | NP_000508.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA2 | ENST00000251595.11 | c.427T>G | p.Ter143Gluext*? | stop_lost | 3/3 | 1 | NM_000517.6 | ENSP00000251595.6 | ||
HBA2 | ENST00000482565.1 | n.563T>G | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
HBA2 | ENST00000397806.1 | c.331T>G | p.Ter111Gluext*? | stop_lost | 3/3 | 2 | ENSP00000380908.1 | |||
ENSG00000290038 | ENST00000702607.1 | n.63A>C | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 149046Hom.: 0 Cov.: 25
GnomAD3 genomes
AF:
AC:
2
AN:
149046
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1459094Hom.: 0 Cov.: 33 AF XY: 0.00000276 AC XY: 2AN XY: 725622
GnomAD4 exome
AF:
AC:
5
AN:
1459094
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
725622
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000134 AC: 2AN: 149046Hom.: 0 Cov.: 25 AF XY: 0.0000137 AC XY: 1AN XY: 72752
GnomAD4 genome
AF:
AC:
2
AN:
149046
Hom.:
Cov.:
25
AF XY:
AC XY:
1
AN XY:
72752
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 07, 2023 | This protein extension has been observed in individual(s) with thalassemia (PMID: 9255612). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs41464951, gnomAD 0.01%). This sequence change disrupts the translational stop signal of the HBA2 mRNA. It is expected to extend the length of the HBA2 protein by 31 additional amino acid residues. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant results in an extension of the HBA2 protein. Other variant(s) that result in a similarly extended protein product (p.*143Glnext*31) have been determined to be pathogenic (PMID: 2298455, 4944483, 6725554, 9057661, 12393486, 20507641). This suggests that these extensions are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 15653). This variant is also known as Hb Seal Rock. - |
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Feb 09, 2024 | The c.427T>G (p.*143Gluext*31) pathogenic variant leads to the replacement of the normal stop codon by a glutamic acid and extension of the alpha-globin chain by 31 amino acids (p.*143Gluext*31). Individuals positive for this variant and the -alpha3.7 deletion have a clinical presentation that is comparable to that of mild Hb H disease (see Hb Var (http://globin.cse.psu.edu/cgi-bin/hbvar/counter) and PMID: 9255612 (1997)). Based on the available information, this variant is classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 05, 2021 | The Hb Seal Rock variant (HBA2: c.427T>G; p.Ter143Glu, also known as Ter142Glu when numbered from the mature protein, rs41464951) is described in the literature in individuals with HbH disease who carry alpha globin deletions on the opposite chromosome (Das 2014, Merritt 1997, see HbVar link). This variant is reported in ClinVar (Variation ID: 15653), and found in the general population with a low overall allele frequency of 0.003% (1/30200 alleles) in the Genome Aggregation Database. This variant abolishes the canonical termination codon, resulting in an elongated protein that is unstable, similar to other stop loss variants (Hb Constant Spring, Hb Icaria)(see HbVar links and references therein). Based on available information, the Hb Seal Rock variant is considered to be pathogenic. References: Link to HbVar database for Hb Constant Spring: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=703&.cgifields=histD Link to HbVar database for Hb Icaria: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=704&.cgifields=histD Link to HbVar database for Hb Seal Rock: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=706&.cgifields=histD Das R et al. Wide Spectrum of Molecular and Clinical Heterogeneity in HbH Disease in North Indian Patients. Blood 124.21 (2014): 1358. Web. 21 Aug. 2018. Merritt D et al. Hb Seal Rock ((alpha 2)142 term-->Glu, codon 142 TAA-->GAA): an extended alpha chain variant associated with anemia, microcytosis, and alpha-thalassemia-2 (-3.7 Kb). Hemoglobin. 1997 Jul;21(4):331-44. - |
alpha Thalassemia Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
HEMOGLOBIN SEAL ROCK Other:1
other, no assertion criteria provided | literature only | OMIM | May 22, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at